Haloperidol decanoate 50 mg in 1 mL Injection
RxNorm 1719862
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1719862 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: haloperidol decanoate 50 mg in 1 mL Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
1 mL haloperidol decanoate 50 mg/ML Injection
(Atom ID: 7704510)
PSNPrescribable
Prescribable Name (PSN):
Haloperidol decanoate 50 mg in 1 mL Injection
(Atom ID: 7704511)
SYPrescribable
Synonym (SY):
Haloperidol decanoate 50 mg per 1 mL Injection
(Atom ID: 7704512)
Patient Education
Haloperidol Injection
Haloperidol injection and haloperidol extended-release injection are used to treat schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Haloperidol injection is also used to control motor tics (uncontrollable need to repeat certain body movements) and verbal tics (uncontrollable need to repeat sounds or words) in people who have Tourette's disorder (condition characterized by motor or verbal tics). Haloperidol is in a class of medications called conventional antipsychotics. It works by decreasing abnormal excitement in the brain.
[Learn More]
* Please review the disclaimer below.